Nifty

:

25722.10

Sensex

:

83938.71

-155.75 (-0.60%)
-465.75 (-0.55%)

Login

Nifty
Sensex

:
:

25722.10
83938.71

-155.75 (-0.60%)
-465.75 (-0.55%)

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

72/99

BSE: 539730 | NSE: Not Listed

Watchlist

NSE BSE

1539.15

31-Oct-2025

Open
High
Low
Previous Close

1620
1620
1537.7
1618.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

17398
26915775
1620
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

726.73
31.00
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

888.33
0.05%
4.90

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

29.96
25.29
15.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

36.76
35.46
22.26

PAT CAGR (%)

10 Years
5 Years
3 Years

50.62
52.40
35.06

P:E (Median)

8 Years
5 Years
3 Years

39.26
40.09
27.08

P:BV (Average)

8 Years
5 Years
3 Years

3.93
4.22
3.70

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.73
18.91
14.20

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 119.85 78.81 52.07% 167.41 118.03 41.84% 102.70 87.01 18.03% 107.35 81.98 30.95%
Expenses 102.86 68.33 50.53% 149.97 106.87 40.33% 89.47 76.49 16.97% 93.40 72.38 29.04%
EBITDA 16.99 10.48 62.12% 17.44 11.17 56.13% 13.23 10.52 25.76% 13.95 9.61 45.16%
EBIDTM 14.18% 13.30% 10.42% 9.46% 12.88% 12.09% 13.00% 11.72%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 6.53 3.91 67.01% 8.15 4.37 86.50% 5.00 3.77 32.63% 5.31 2.90 83.10%
Depreciation 1.42 1.05 35.24% 1.25 0.96 30.21% 1.09 0.99 10.10% 1.06 0.94 12.77%
PBT 9.04 5.52 63.77% 8.04 5.84 37.67% 7.13 5.76 23.78% 7.58 5.77 31.37%
Tax 2.27 1.39 63.31% 0.97 0.78 24.36% 1.80 1.54 16.88% 3.30 1.83 80.33%
PAT 6.77 4.13 63.92% 7.07 5.06 39.72% 5.33 4.22 26.30% 4.27 3.94 8.38%
PATM 5.64% 5.24% 4.22% 4.29% 5.19% 4.85% 3.98% 4.80%
EPS 14.39 8.79 63.71% 15.05 10.77 39.74% 11.35 8.98 26.39% 9.09 8.38 8.47%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 119.85 0.00 0 167.41 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 102.86 0.00 0 150.16 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 16.99 0.00 0 17.25 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 14.18% 0.00% 10.30% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 6.53 0.00 0 8.15 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 1.42 0.00 0 1.84 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 9.04 0.00 0 7.26 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 2.27 0.00 0 1.26 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 6.77 0.00 0 6.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 5.64% 0.00% 3.59% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 14.33 0.00 0 12.71 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 497.31 348.16 274.68 224.46 133.89 112.77 97.02 59.55 56.70 42.32 25.33 Net Sales Growth 35.94% 26.75% 22.37% 67.65% 18.73% 16.23% 62.92% 5.03% 33.98% 67.07% Cost Of Goods Sold 356.89 261.32 208.68 177.10 102.25 81.75 59.88 39.51 24.57 19.04 15.31 Gross Profit 140.42 86.83 65.99 47.35 31.65 31.02 37.14 20.04 32.12 23.29 10.02 GP Margin 28.24% 24.94% 24.02% 21.10% 23.64% 27.51% 38.28% 33.65% 56.65% 55.03% 39.56% Total Expenditure 435.70 310.17 246.90 210.55 124.55 104.44 86.99 53.84 53.37 38.42 23.67 Power & Fuel Cost - 4.47 3.37 3.49 2.94 3.10 2.75 1.60 1.64 1.17 0.84 % Of Sales - 1.28% 1.23% 1.55% 2.20% 2.75% 2.83% 2.69% 2.89% 2.76% 3.32% Employee Cost - 12.50 11.54 10.66 8.66 8.95 8.04 5.19 4.92 3.83 3.22 % Of Sales - 3.59% 4.20% 4.75% 6.47% 7.94% 8.29% 8.72% 8.68% 9.05% 12.71% Manufacturing Exp. - 10.34 7.24 4.41 3.13 3.58 4.03 1.21 15.32 9.47 0.70 % Of Sales - 2.97% 2.64% 1.96% 2.34% 3.17% 4.15% 2.03% 27.02% 22.38% 2.76% General & Admin Exp. - 15.85 10.81 8.72 5.47 5.19 7.13 3.57 3.34 1.93 1.72 % Of Sales - 4.55% 3.94% 3.88% 4.09% 4.60% 7.35% 5.99% 5.89% 4.56% 6.79% Selling & Distn. Exp. - 5.07 4.24 5.61 1.77 1.76 2.59 2.54 3.46 2.71 1.64 % Of Sales - 1.46% 1.54% 2.50% 1.32% 1.56% 2.67% 4.27% 6.10% 6.40% 6.47% Miscellaneous Exp. - 0.62 1.00 0.56 0.33 0.11 2.57 0.21 0.11 0.27 1.64 % Of Sales - 0.18% 0.36% 0.25% 0.25% 0.10% 2.65% 0.35% 0.19% 0.64% 0.95% EBITDA 61.61 37.99 27.78 13.91 9.34 8.33 10.03 5.71 3.33 3.90 1.66 EBITDA Margin 12.39% 10.91% 10.11% 6.20% 6.98% 7.39% 10.34% 9.59% 5.87% 9.22% 6.55% Other Income 0.00 0.92 1.82 1.63 1.40 0.52 0.58 0.16 1.91 0.86 0.49 Interest 24.99 13.65 9.28 4.78 4.37 4.47 3.12 1.95 1.87 2.06 1.05 Depreciation 4.82 3.80 2.81 2.16 2.00 1.88 1.33 1.29 1.14 0.80 0.55 PBT 31.79 21.45 17.51 8.60 4.37 2.49 6.16 2.64 2.23 1.90 0.55 Tax 8.34 5.83 6.70 2.26 1.19 0.59 1.70 0.89 0.80 0.77 0.26 Tax Rate 26.23% 27.18% 38.26% 26.28% 37.07% 23.69% 27.60% 33.71% 35.87% 41.85% 50.00% PAT 23.44 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 1.07 0.26 PAT before Minority Interest 23.44 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 1.07 0.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.71% 4.49% 3.94% 2.82% 1.50% 1.68% 4.60% 2.94% 2.52% 2.53% 1.03% PAT Growth 35.10% 44.50% 70.50% 215.42% 5.79% -57.40% 154.86% 22.38% 33.64% 311.54% EPS 49.87 33.23 23.00 13.49 4.28 4.04 9.49 3.72 3.04 2.28 0.55

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 121.47 96.38 68.06 43.07 41.32 38.99 22.16 7.26 3.96 3.08 Share Capital 4.70 4.53 4.43 3.99 3.99 3.99 3.43 4.87 2.62 2.62 Total Reserves 115.20 83.52 63.42 39.08 37.33 35.00 18.74 2.39 1.34 0.46 Non-Current Liabilities 19.30 21.25 45.18 32.09 14.07 12.51 4.06 8.37 7.31 3.69 Secured Loans 12.80 15.44 42.04 29.11 11.50 10.64 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.24 6.19 2.94 Long Term Provisions 2.37 1.96 1.71 1.60 1.63 1.08 3.25 0.28 0.43 0.21 Current Liabilities 166.83 139.66 73.75 86.46 85.99 53.41 53.04 40.47 31.93 16.22 Trade Payables 62.95 59.34 48.62 59.96 46.22 33.70 38.92 22.83 16.27 6.99 Other Current Liabilities 11.59 8.31 11.62 14.84 13.79 8.94 1.33 7.75 7.18 2.82 Short Term Borrowings 86.76 67.71 10.72 10.53 23.41 8.63 9.90 7.58 6.85 5.10 Short Term Provisions 5.54 4.29 2.79 1.13 2.57 2.13 2.89 2.31 1.62 1.31 Total Liabilities 307.60 257.29 186.99 161.62 141.38 104.91 79.26 56.10 43.20 22.99 Net Block 46.57 38.93 32.34 30.35 30.97 31.35 16.28 20.50 14.51 7.92 Gross Block 62.98 51.54 42.14 37.99 36.61 35.11 25.00 27.93 20.80 13.40 Accumulated Depreciation 16.40 12.61 9.80 7.64 5.64 3.76 8.71 7.43 6.29 5.49 Non Current Assets 50.40 41.07 34.34 31.54 32.05 32.39 27.78 20.85 14.92 9.81 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 11.15 0.00 0.00 1.41 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 3.36 2.13 2.00 1.18 1.08 1.03 0.35 0.35 0.31 0.48 Other Non Current Assets 0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.00 Current Assets 257.20 216.21 152.65 130.08 109.32 72.52 51.48 35.24 28.28 13.08 Current Investments 0.81 0.31 0.06 0.06 0.05 0.00 0.00 0.00 0.00 0.00 Inventories 175.00 150.12 46.46 67.57 50.46 40.78 18.43 6.94 10.27 4.29 Sundry Debtors 64.85 34.56 90.27 41.08 38.97 17.78 15.26 20.38 11.40 5.19 Cash & Bank 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60 Other Current Assets 15.20 0.75 0.58 0.36 16.78 12.49 16.35 7.18 5.22 3.00 Short Term Loans & Adv. 13.76 27.03 13.20 19.89 16.49 0.75 7.70 6.31 5.01 1.05 Net Current Assets 90.37 76.55 78.90 43.63 23.33 19.11 -1.56 -5.23 -3.65 -3.14 Total Assets 307.60 257.28 186.99 161.62 141.37 104.91 79.26 56.09 43.20 23.00

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 3.33 1.78 PBT 21.45 17.46 8.58 2.01 2.35 6.18 1.75 2.23 1.83 0.52 Adjustment 16.77 11.70 7.82 8.65 6.03 2.08 2.67 2.00 1.74 1.15 Changes in Working Capital -38.66 -43.57 -18.77 -10.50 -19.02 -7.43 12.88 -0.25 -0.25 0.11 Cash after chg. in Working capital -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 3.33 1.78 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.64 -9.40 -4.14 -1.39 -1.49 -5.25 -8.21 -7.13 -5.99 -3.00 Net Fixed Assets -11.44 -9.40 -4.15 -1.38 -1.50 1.04 -8.22 -7.13 -5.99 -2.71 Net Investments -0.50 -0.25 0.00 -0.01 -0.05 0.00 0.00 0.00 0.00 0.00 Others 4.30 0.25 0.01 0.00 0.06 -6.29 0.01 0.00 0.00 -0.29 Cash from Financing Activity 5.99 25.18 7.47 -0.71 13.73 4.43 -8.38 2.52 3.45 1.40 Net Cash Inflow / Outflow -2.08 1.36 0.94 -1.93 1.59 0.01 0.70 -0.64 0.79 0.18 Opening Cash & Equivalents 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60 0.42 Closing Cash & Equivalent 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 255.15 194.27 153.07 107.96 103.57 97.73 64.71 20.14 15.68 11.50 ROA 5.53% 4.86% 3.63% 1.33% 1.54% 4.84% 2.59% 2.88% 3.23% 1.26% ROE 15.03% 13.86% 11.42% 4.77% 4.74% 14.59% 13.02% 33.88% 33.46% 9.68% ROCE 17.13% 17.64% 13.15% 9.53% 10.36% 20.56% 15.90% 18.16% 24.67% 14.23% Fixed Asset Turnover 6.08 5.86 5.60 3.59 3.14 3.23 2.25 2.33 2.47 1.99 Receivable days 52.11 82.94 106.79 109.11 91.85 62.16 109.23 102.30 71.54 62.01 Inventory Days 170.43 130.61 92.72 160.89 147.66 111.37 77.73 55.39 62.77 56.62 Payable days 85.40 94.41 111.88 189.53 178.44 158.25 217.97 146.17 106.16 100.81 Cash Conversion Cycle 137.13 119.14 87.63 80.47 61.07 15.28 -31.02 11.52 28.15 17.82 Total Debt/Equity 0.88 0.98 0.78 0.92 0.84 0.49 0.45 2.53 3.92 3.06 Interest Cover 2.57 2.89 2.80 1.73 1.56 2.97 2.36 2.19 1.89 1.50

Top Investors:

nikhil kishorchandra vora

arun kumar mukherjee

harsha venkatesh

Annual Reports:

News Update:

Fredun Pharmaceuticals launches ‘Snacky Jain’
13th Oct 2025, 14:43 PM

Snacky Jain is India’s first Jain functional food product specifically for pets
Read More
Fredun Pharmaceuticals acquires Wagr
9th Oct 2025, 18:00 PM

This strategic move positions FPL at the forefront of India's rapidly growing pet care industry, projected to reach $6 billion by 2030
Read More
Fredun Pharma - Quarterly Results
30th Jul 2025, 18:54 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback